New trial finds first-ever Alzheimer’s drug to slow cognitive decline
Pharmaceutical companies Eisai and Biogen have announced the first results from a Phase 3 human trial testing a drug designed to treat symptoms of dementia associated with Alzheimer’s disease. The drug seems to be successful at slowing cognitive decline, making it the first drug to ever effectively treat Alzheimer’s symptoms. However, experts are cautious in their optimism, suggesting more information is needed to understand exactly how meaningful this treatment will be for patients in the real world.
Category: Health & Wellbeing, Lifestyle
Tags: Alzheimer’s Disease, Dementia, Brain, antibodies, Drugs
Continue reading New trial finds first-ever Alzheimer’s drug to slow cognitive decline